Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics

Area of Science:

• Psychoactive Substance Analysis
• Public Health Interventions
• Harm Reduction Strategies

Background:

• Unregulated classic psychedelics (LSD, psilocybin, DMT) carry risks due to unknown adulterants and potencies.
• Drug checking services are crucial for mitigating harm among users of these substances.
• Existing analytical methods and intervention settings present both opportunities and challenges.

Purpose of the Study:

• To explore the importance of drug checking for classic psychedelic users.
• To examine analytical techniques for identifying psychedelic substances.
• To assess risk communication strategies and intervention settings in drug checking.

Main Methods:

• Utilized Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) for reliable analysis.
• Employed presumptive tests like Thin-Layer Chromatography (TLC) and reagent testing for cost-effective screening.
• Incorporated Fourier-transform infrared spectroscopy (FTIR) as a complementary technique, acknowledging its limitations.

Main Results:

• GC-MS and LC-MS offer comprehensive but costly and stationary analysis.
• TLC and reagent testing provide efficient initial screening.
• FTIR can be limited by detection limits for certain compounds and matrices, necessitating multiple analytical methods.
• Combining methods enhances acute risk prevention, while instrumental analysis is key for public health monitoring.

Conclusions:

• Drug checking, combining robust testing with consultation, is a key public health measure.
• It effectively reduces acute harm from misrepresented psychedelic substances.
• It aids in monitoring dangerous or novel substances and informs public health efforts.